We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

To Assess the Predictive Value of D-dimer Level on the Occurrence of Cardiovascular Events (COAGFAII)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01224574
First Posted: October 20, 2010
Last Update Posted: October 20, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Ministry of Health, France
Information provided by:
Hopital Lariboisière
September 13, 2010
October 20, 2010
October 20, 2010
January 2001
July 2006   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
To Assess the Predictive Value of D-dimer Level on the Occurrence of Cardiovascular Events
Place Des D-dimères Dans la Prise en Charge Des Patients en Fibrillation Auriculaire : Evaluation de la Valeur prédictive Des D-dimères Sur la Survenue d'événements Thromboemboliques
The primary aim of the study was to assess whether D-Dimer level at entry or an increase of D-Dimer level during the follow-up could predict the occurrence of subsequent cardiovascular events in patients with atrial fibrillation.
Patients will be followed-up every 4 months with clinical assessment and D-dimer blinded measurement.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
No biospecimens are to be retained
Non-Probability Sample
Patients with atrial fibrillation encountered in usual care
Atrial Fibrillation
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
425
July 2007
July 2006   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • atrial fibrillation

Exclusion Criteria:

  • follow-up not possible, poor prognosis within 3 months
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
France
 
 
NCT01224574
AOR 01 029
No
Not Provided
Not Provided
Projet Hospitalier de Recherche Clinique Régional, Direction de la Recherche Clinique
Hopital Lariboisière
Ministry of Health, France
Principal Investigator: Isabelle Mahé, MD,PhD Hopital Lariboisière
Hopital Lariboisière
September 2010